封面
市场调查报告书
商品编码
1600229

智慧吸入器市场:按产品类型、适应症、分销管道划分 - 全球预测 2025-2030

Smart Inhalers Market by Product Type (Dry Powder Inhalers, Metered-Dose Inhalers), Indication (Asthma, COPD), Distribution Channel - Global Forecast 2025-2030

出版日期: | 出版商: 360iResearch | 英文 195 Pages | 商品交期: 最快1-2个工作天内

价格

本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

2023年智慧吸入器市值为11.8亿美元,预计2024年将达到14.5亿美元,复合年增长率为22.84%,到2030年将达到49.8亿美元。

智慧吸入器是先进的呼吸系统护理设备,整合了感测器和行动应用程式等技术,可追踪和优化气喘和慢性阻塞性肺病等疾病的用药依从性。对智慧吸入器的需求源于提高用药依从性的迫切需要,传统吸入器导致依从性差,导致症状控制不佳并增加医疗费用。这些设备提供即时药物监测、使用情况追踪和自动管理记录,以提高患者参与度和健康结果。主要最终用户包括希望利用资料加强疾病管理和治疗研究的个别患者、医疗保健提供者和研究机构。

主要市场统计
基准年[2023] 11.8亿美元
预测年份 [2024] 14.5亿美元
预测年份 [2030] 49.8亿美元
复合年增长率(%) 22.84%

关键的成长要素包括呼吸系统疾病的日益普及、对个人化医疗保健的需求不断增加以及物联网设备的技术进步。政府倡议的增加、有利的报销政策和监管支持将进一步推动市场渗透。 COVID-19 大流行加速了数位医疗保健的采用,也为智慧吸入器市场带来了动力。关键的发展机会在于开拓的新兴市场以及配备人工智慧和机器学习的多功能智慧吸入器的开发,以进行病情恶化预测分析。

然而,市场成长面临高成本、资料隐私问题以及欠发达地区缺乏意识和基础设施等挑战。此外,技术复杂性以及不断改进和检验的需要也是主要障碍。

创新和研究应着重于增强设备连接性、扩大与各种吸入药物的兼容性以及简化使用者介面以促进更广泛的采用。开发将智慧吸入器与全面的数位健康生态系统相结合的整合平台具有潜力,提供无缝的患者与医生互动和个人化的治疗计划。市场正在快速成长,但需要灵活的适应和持续的研发投资来解决限制。进入新兴市场的公司正在寻求与科技公司和医疗保健提供者合作,共同开发满足这些多方面需求的解决方案,同时确保强大的资料安全性和用户信任。

市场动态:揭示快速发展的智慧吸入器市场的关键市场洞察

供需的动态交互作用正在改变智慧吸入器市场。透过了解这些不断变化的市场动态,公司可以准备好做出明智的投资决策、完善策略决策并抓住新的商机。全面了解这些趋势可以帮助企业降低政治、地理、技术、社会和经济领域的风险,同时消费行为及其对製造成本的影响以及对采购趋势的影响。

  • 市场驱动因素
    • 全球呼吸系统疾病盛行率不断上升
    • 人们越来越意识到数位健康和​​连网型设备的好处
  • 市场限制因素
    • 开发智慧吸入器成本高昂
  • 市场机会
    • 更多新型智慧吸入器介绍
    • 智慧吸入器製造商与软体公司之间的数位健康伙伴关係
  • 市场挑战
    • 智慧吸入器的技术局​​限性

波特五力:驾驭智慧吸入器市场的策略工具

波特的五力框架是理解市场竞争格局的重要工具。波特的五力框架为评估公司的竞争地位和探索策略机会提供了清晰的方法。该框架可帮助公司评估市场动态并确定新业务的盈利。这些见解使公司能够利用自己的优势,解决弱点并避免潜在的挑战,从而确保更强大的市场地位。

PESTLE分析:了解智慧吸入器市场的外部影响

外部宏观环境因素在塑造智慧吸入器市场的表现动态方面发挥着至关重要的作用。对政治、经济、社会、技术、法律和环境因素的分析提供了应对这些影响所需的资讯。透过调查 PESTLE 因素,公司可以更了解潜在的风险和机会。这种分析可以帮助公司预测法规、消费者偏好和经济趋势的变化,并为他们做出积极主动的决策做好准备。

市场占有率分析 了解智慧吸入器市场的竞争格局

对智慧吸入器市场的详细市场占有率分析可以对供应商的绩效进行全面评估。公司可以透过比较收益、客户群和成长率等关键指标来揭示自己的竞争定位。该分析揭示了市场集中、分散和整合的趋势,为供应商提供了製定策略决策所需的洞察力,使他们能够在日益激烈的竞争中占有一席之地。

FPNV 定位矩阵智慧吸入器市场供应商的绩效评估

FPNV定位矩阵是评估智慧吸入器市场供应商的重要工具。此矩阵允许业务组织根据供应商的商务策略和产品满意度评估供应商,从而做出符合其目标的明智决策。这四个象限使您能够清晰、准确地划分供应商,并确定最能满足您的策略目标的合作伙伴和解决方案。

策略分析和建议绘製智慧吸入器市场的成功之路

对于旨在加强其在全球市场的影响力的公司来说,智慧吸入器市场的策略分析至关重要。透过审查关键资源、能力和绩效指标,公司可以识别成长机会并努力改进。这种方法使您能够克服竞争环境中的挑战,利用新的商机,并取得长期成功。

本报告对市场进行了全面分析,涵盖关键重点领域:

1. 市场渗透率:对当前市场环境的详细审查、主要企业的广泛资料、对其在市场中的影响力和整体影响力的评估。

2. 市场开拓:辨识新兴市场的成长机会,评估现有领域的扩张潜力,并提供未来成长的策略蓝图。

3. 市场多元化:分析近期产品发布、开拓地区、关键产业进展、塑造市场的策略投资。

4. 竞争评估与情报:彻底分析竞争格局,检验市场占有率、业务策略、产品系列、认证、监理核准、专利趋势、主要企业的技术进步等。

5. 产品开发与创新:重点在于有望推动未来市场成长的最尖端科技、研发活动和产品创新。

我们也回答重要问题,帮助相关人员做出明智的决策:

1.目前的市场规模和未来的成长预测是多少?

2. 哪些产品、区隔市场和地区提供最佳投资机会?

3.塑造市场的主要技术趋势和监管影响是什么?

4.主要厂商的市场占有率和竞争地位如何?

5. 推动供应商市场进入和退出策略的收益来源和策略机会是什么?

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 全球呼吸道疾病流行
      • 人们越来越意识到数位健康和​​连网型设备的好处
    • 抑制因素
      • 智慧吸入器开发成本高
    • 机会
      • Novel Rise 推出智慧吸入器
      • 智慧吸入器製造商与软体公司之间的数位健康伙伴关係
    • 任务
      • 智慧型吸入器的某些技术限制
  • 市场区隔分析
    • 产品类型:干粉吸入器越来越多地用于简化给药过程。
    • 分销管道:透过线上分销管道扩大智慧吸入器产品
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 经济
    • 社群
    • 技术的
    • 合法地
    • 环境

第六章智慧吸入器市场:依产品类型

  • 干粉吸入器
  • 定量吸入器

第七章智慧吸入器市场(按适应症)

  • 气喘
  • 慢性阻塞性肺病

第八章智慧吸入器市场:依分销管道划分

  • 离线
    • 医院药房
    • 零售药房
  • 在线的

第九章美洲智慧吸入器市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第十章亚太智慧吸入器市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十一章 欧洲、中东和非洲智慧吸入器市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十二章竞争格局

  • 2023 年市场占有率分析
  • FPNV 定位矩阵,2023
  • 竞争情境分析
    • 由 NHS 资助的莱斯特研究使用智慧吸入器来加强高风险儿童的气喘管理,并旨在更广泛地采用。
    • FDA核准Astra Zeneca创新 Hailie Smartinhaler 用于吸入器
    • Teva 的智慧吸入器 GoResp Digihaler 在英国推出
  • 战略分析和建议

公司名单

  • 3M Company
  • Adherium Limited
  • AptarGroup, Inc.
  • Boehringer Ingelheim group
  • Cipla Limited
  • Cognita Labs, LLC
  • Cohero Health, Inc.
  • FindAir Sp. z oo
  • GlaxoSmithKline PLC
  • Glenmark Pharmaceuticals
  • Nemera Development SA
  • Omron Corporation
  • OPKO Health, Inc.
  • PARI GmbH
  • ResMed Inc.
  • Sensirion Holding AG
  • Teva Pharmaceutical Industries Limited
  • Vectura Group Limited
  • Vectura Group Ltd.
Product Code: MRR-430D42AA0D6F

The Smart Inhalers Market was valued at USD 1.18 billion in 2023, expected to reach USD 1.45 billion in 2024, and is projected to grow at a CAGR of 22.84%, to USD 4.98 billion by 2030.

Smart inhalers are advanced respiratory management devices that integrate technology, such as sensors and mobile applications, to track and optimize medication adherence for conditions like asthma and COPD. The necessity for smart inhalers arises from the urgent need to improve medication compliance, which stands low with traditional inhalers, contributing to uncontrolled symptoms and higher healthcare costs. These devices offer real-time medication monitoring, usage tracking, and automatic dose recording, enhancing patient engagement and health outcomes. Primary end-users encompass individual patients, healthcare providers, and research institutions aiming to leverage data for enhanced disease management and therapeutic research.

KEY MARKET STATISTICS
Base Year [2023] USD 1.18 billion
Estimated Year [2024] USD 1.45 billion
Forecast Year [2030] USD 4.98 billion
CAGR (%) 22.84%

Key growth factors include the increasing prevalence of respiratory diseases, the rising demand for personalized healthcare, and technological advancements in IoT devices. Increased governmental initiatives, favorable reimbursement policies, and regulatory support further drive market penetration. Digital healthcare adoption accelerated by the COVID-19 pandemic, also lends momentum to the smart inhalers market. Key opportunities lie within untapped emerging markets and in the development of multi-functional smart inhalers equipped with AI and machine learning for predictive analytics of exacerbations.

However, market growth faces challenges such as high costs, data privacy concerns, and a lack of awareness and infrastructure in underdeveloped regions. Moreover, technical complexities and the need for constant improvements and validation pose significant barriers.

Innovation and research should focus on enhancing device connectivity, expanding compatibility with various inhaled medications, and simplifying user interfaces to ensure broader adoption. There is potential in developing integrated platforms that combine smart inhalers with comprehensive digital health ecosystems, offering seamless patient-physician interaction, and personalized treatment plans. The market, while burgeoning, demands agile adaptation and continual investment in R&D to address limitations. Companies entering the market should focus on collaborations with tech firms and healthcare providers to co-develop solutions that address these multifaceted needs while ensuring robust data security and user trust.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Smart Inhalers Market

The Smart Inhalers Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Increasing prevalence of respiratory diseases globally
    • Rising awareness associated withthe benefits of digital health and connected devices
  • Market Restraints
    • High cost of development of smart inhalers
  • Market Opportunities
    • Rising introduction of novel smart inhalers
    • Digital health partnerships between smart inhaler manufacturers and software companies
  • Market Challenges
    • Certain technological limitations with the smart inhaler

Porter's Five Forces: A Strategic Tool for Navigating the Smart Inhalers Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Smart Inhalers Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Smart Inhalers Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Smart Inhalers Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Smart Inhalers Market

A detailed market share analysis in the Smart Inhalers Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Smart Inhalers Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Smart Inhalers Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Smart Inhalers Market

A strategic analysis of the Smart Inhalers Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Smart Inhalers Market, highlighting leading vendors and their innovative profiles. These include 3M Company, Adherium Limited, AptarGroup, Inc., Boehringer Ingelheim group, Cipla Limited, Cognita Labs, LLC, Cohero Health, Inc., FindAir Sp. z o. o., GlaxoSmithKline PLC, Glenmark Pharmaceuticals, Nemera Development S.A., Omron Corporation, OPKO Health, Inc., PARI GmbH, ResMed Inc., Sensirion Holding AG, Teva Pharmaceutical Industries Limited, Vectura Group Limited, and Vectura Group Ltd..

Market Segmentation & Coverage

This research report categorizes the Smart Inhalers Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Product Type, market is studied across Dry Powder Inhalers and Metered-Dose Inhalers.
  • Based on Indication, market is studied across Asthma and COPD.
  • Based on Distribution Channel, market is studied across Offline and Online. The Offline is further studied across Hospital Pharmacies and Retail Pharmacies.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increasing prevalence of respiratory diseases globally
      • 5.1.1.2. Rising awareness associated withthe benefits of digital health and connected devices
    • 5.1.2. Restraints
      • 5.1.2.1. High cost of development of smart inhalers
    • 5.1.3. Opportunities
      • 5.1.3.1. Rising introduction of novel smart inhalers
      • 5.1.3.2. Digital health partnerships between smart inhaler manufacturers and software companies
    • 5.1.4. Challenges
      • 5.1.4.1. Certain technological limitations with the smart inhaler
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Product Type: Growing usage of dry powder inhalers as it simplifies the medication delivery process
    • 5.2.2. Distribution Channel: Growing availability of smart inhalers through online distribution channel
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Smart Inhalers Market, by Product Type

  • 6.1. Introduction
  • 6.2. Dry Powder Inhalers
  • 6.3. Metered-Dose Inhalers

7. Smart Inhalers Market, by Indication

  • 7.1. Introduction
  • 7.2. Asthma
  • 7.3. COPD

8. Smart Inhalers Market, by Distribution Channel

  • 8.1. Introduction
  • 8.2. Offline
    • 8.2.1. Hospital Pharmacies
    • 8.2.2. Retail Pharmacies
  • 8.3. Online

9. Americas Smart Inhalers Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Smart Inhalers Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa Smart Inhalers Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. Market Share Analysis, 2023
  • 12.2. FPNV Positioning Matrix, 2023
  • 12.3. Competitive Scenario Analysis
    • 12.3.1. NHS-Funded Leicester Study Harnesses Smart Inhalers to Enhance Asthma Management Among High-Risk Children, Aiming for Broader Adoption
    • 12.3.2. FDA Clears Innovative Hailie Smartinhaler for AstraZeneca Inhalers
    • 12.3.3. Teva's Smart Inhaler GoResp Digihaler Launches in UK
  • 12.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. 3M Company
  • 2. Adherium Limited
  • 3. AptarGroup, Inc.
  • 4. Boehringer Ingelheim group
  • 5. Cipla Limited
  • 6. Cognita Labs, LLC
  • 7. Cohero Health, Inc.
  • 8. FindAir Sp. z o. o.
  • 9. GlaxoSmithKline PLC
  • 10. Glenmark Pharmaceuticals
  • 11. Nemera Development S.A.
  • 12. Omron Corporation
  • 13. OPKO Health, Inc.
  • 14. PARI GmbH
  • 15. ResMed Inc.
  • 16. Sensirion Holding AG
  • 17. Teva Pharmaceutical Industries Limited
  • 18. Vectura Group Limited
  • 19. Vectura Group Ltd.

LIST OF FIGURES

  • FIGURE 1. SMART INHALERS MARKET RESEARCH PROCESS
  • FIGURE 2. SMART INHALERS MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL SMART INHALERS MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL SMART INHALERS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL SMART INHALERS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL SMART INHALERS MARKET SIZE, BY PRODUCT TYPE, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL SMART INHALERS MARKET SIZE, BY PRODUCT TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL SMART INHALERS MARKET SIZE, BY INDICATION, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL SMART INHALERS MARKET SIZE, BY INDICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL SMART INHALERS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL SMART INHALERS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. AMERICAS SMART INHALERS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 13. AMERICAS SMART INHALERS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. UNITED STATES SMART INHALERS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 15. UNITED STATES SMART INHALERS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. ASIA-PACIFIC SMART INHALERS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. ASIA-PACIFIC SMART INHALERS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. EUROPE, MIDDLE EAST & AFRICA SMART INHALERS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. EUROPE, MIDDLE EAST & AFRICA SMART INHALERS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. SMART INHALERS MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 21. SMART INHALERS MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. SMART INHALERS MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL SMART INHALERS MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL SMART INHALERS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL SMART INHALERS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. SMART INHALERS MARKET DYNAMICS
  • TABLE 7. GLOBAL SMART INHALERS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL SMART INHALERS MARKET SIZE, BY DRY POWDER INHALERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL SMART INHALERS MARKET SIZE, BY METERED-DOSE INHALERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL SMART INHALERS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL SMART INHALERS MARKET SIZE, BY ASTHMA, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL SMART INHALERS MARKET SIZE, BY COPD, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL SMART INHALERS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL SMART INHALERS MARKET SIZE, BY OFFLINE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL SMART INHALERS MARKET SIZE, BY HOSPITAL PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL SMART INHALERS MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL SMART INHALERS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL SMART INHALERS MARKET SIZE, BY ONLINE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. AMERICAS SMART INHALERS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 20. AMERICAS SMART INHALERS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 21. AMERICAS SMART INHALERS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 22. AMERICAS SMART INHALERS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
  • TABLE 23. AMERICAS SMART INHALERS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 24. ARGENTINA SMART INHALERS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 25. ARGENTINA SMART INHALERS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 26. ARGENTINA SMART INHALERS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 27. ARGENTINA SMART INHALERS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
  • TABLE 28. BRAZIL SMART INHALERS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 29. BRAZIL SMART INHALERS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 30. BRAZIL SMART INHALERS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 31. BRAZIL SMART INHALERS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
  • TABLE 32. CANADA SMART INHALERS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 33. CANADA SMART INHALERS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 34. CANADA SMART INHALERS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 35. CANADA SMART INHALERS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
  • TABLE 36. MEXICO SMART INHALERS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 37. MEXICO SMART INHALERS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 38. MEXICO SMART INHALERS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 39. MEXICO SMART INHALERS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
  • TABLE 40. UNITED STATES SMART INHALERS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 41. UNITED STATES SMART INHALERS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 42. UNITED STATES SMART INHALERS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 43. UNITED STATES SMART INHALERS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
  • TABLE 44. UNITED STATES SMART INHALERS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 45. ASIA-PACIFIC SMART INHALERS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 46. ASIA-PACIFIC SMART INHALERS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 47. ASIA-PACIFIC SMART INHALERS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 48. ASIA-PACIFIC SMART INHALERS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
  • TABLE 49. ASIA-PACIFIC SMART INHALERS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 50. AUSTRALIA SMART INHALERS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 51. AUSTRALIA SMART INHALERS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 52. AUSTRALIA SMART INHALERS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 53. AUSTRALIA SMART INHALERS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
  • TABLE 54. CHINA SMART INHALERS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 55. CHINA SMART INHALERS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 56. CHINA SMART INHALERS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 57. CHINA SMART INHALERS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
  • TABLE 58. INDIA SMART INHALERS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 59. INDIA SMART INHALERS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 60. INDIA SMART INHALERS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 61. INDIA SMART INHALERS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
  • TABLE 62. INDONESIA SMART INHALERS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 63. INDONESIA SMART INHALERS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 64. INDONESIA SMART INHALERS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 65. INDONESIA SMART INHALERS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
  • TABLE 66. JAPAN SMART INHALERS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 67. JAPAN SMART INHALERS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 68. JAPAN SMART INHALERS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 69. JAPAN SMART INHALERS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
  • TABLE 70. MALAYSIA SMART INHALERS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 71. MALAYSIA SMART INHALERS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 72. MALAYSIA SMART INHALERS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 73. MALAYSIA SMART INHALERS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
  • TABLE 74. PHILIPPINES SMART INHALERS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 75. PHILIPPINES SMART INHALERS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 76. PHILIPPINES SMART INHALERS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 77. PHILIPPINES SMART INHALERS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
  • TABLE 78. SINGAPORE SMART INHALERS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 79. SINGAPORE SMART INHALERS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 80. SINGAPORE SMART INHALERS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 81. SINGAPORE SMART INHALERS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
  • TABLE 82. SOUTH KOREA SMART INHALERS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 83. SOUTH KOREA SMART INHALERS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 84. SOUTH KOREA SMART INHALERS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 85. SOUTH KOREA SMART INHALERS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
  • TABLE 86. TAIWAN SMART INHALERS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 87. TAIWAN SMART INHALERS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 88. TAIWAN SMART INHALERS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 89. TAIWAN SMART INHALERS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
  • TABLE 90. THAILAND SMART INHALERS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 91. THAILAND SMART INHALERS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 92. THAILAND SMART INHALERS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 93. THAILAND SMART INHALERS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
  • TABLE 94. VIETNAM SMART INHALERS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 95. VIETNAM SMART INHALERS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 96. VIETNAM SMART INHALERS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 97. VIETNAM SMART INHALERS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
  • TABLE 98. EUROPE, MIDDLE EAST & AFRICA SMART INHALERS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 99. EUROPE, MIDDLE EAST & AFRICA SMART INHALERS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 100. EUROPE, MIDDLE EAST & AFRICA SMART INHALERS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 101. EUROPE, MIDDLE EAST & AFRICA SMART INHALERS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
  • TABLE 102. EUROPE, MIDDLE EAST & AFRICA SMART INHALERS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 103. DENMARK SMART INHALERS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 104. DENMARK SMART INHALERS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 105. DENMARK SMART INHALERS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 106. DENMARK SMART INHALERS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
  • TABLE 107. EGYPT SMART INHALERS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 108. EGYPT SMART INHALERS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 109. EGYPT SMART INHALERS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 110. EGYPT SMART INHALERS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
  • TABLE 111. FINLAND SMART INHALERS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 112. FINLAND SMART INHALERS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 113. FINLAND SMART INHALERS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 114. FINLAND SMART INHALERS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
  • TABLE 115. FRANCE SMART INHALERS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 116. FRANCE SMART INHALERS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 117. FRANCE SMART INHALERS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 118. FRANCE SMART INHALERS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
  • TABLE 119. GERMANY SMART INHALERS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 120. GERMANY SMART INHALERS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 121. GERMANY SMART INHALERS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 122. GERMANY SMART INHALERS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
  • TABLE 123. ISRAEL SMART INHALERS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 124. ISRAEL SMART INHALERS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 125. ISRAEL SMART INHALERS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 126. ISRAEL SMART INHALERS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
  • TABLE 127. ITALY SMART INHALERS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 128. ITALY SMART INHALERS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 129. ITALY SMART INHALERS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 130. ITALY SMART INHALERS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
  • TABLE 131. NETHERLANDS SMART INHALERS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 132. NETHERLANDS SMART INHALERS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 133. NETHERLANDS SMART INHALERS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 134. NETHERLANDS SMART INHALERS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
  • TABLE 135. NIGERIA SMART INHALERS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 136. NIGERIA SMART INHALERS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 137. NIGERIA SMART INHALERS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 138. NIGERIA SMART INHALERS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
  • TABLE 139. NORWAY SMART INHALERS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 140. NORWAY SMART INHALERS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 141. NORWAY SMART INHALERS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 142. NORWAY SMART INHALERS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
  • TABLE 143. POLAND SMART INHALERS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 144. POLAND SMART INHALERS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 145. POLAND SMART INHALERS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 146. POLAND SMART INHALERS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
  • TABLE 147. QATAR SMART INHALERS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 148. QATAR SMART INHALERS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 149. QATAR SMART INHALERS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 150. QATAR SMART INHALERS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
  • TABLE 151. RUSSIA SMART INHALERS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 152. RUSSIA SMART INHALERS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 153. RUSSIA SMART INHALERS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 154. RUSSIA SMART INHALERS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
  • TABLE 155. SAUDI ARABIA SMART INHALERS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 156. SAUDI ARABIA SMART INHALERS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 157. SAUDI ARABIA SMART INHALERS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 158. SAUDI ARABIA SMART INHALERS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
  • TABLE 159. SOUTH AFRICA SMART INHALERS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 160. SOUTH AFRICA SMART INHALERS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 161. SOUTH AFRICA SMART INHALERS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 162. SOUTH AFRICA SMART INHALERS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
  • TABLE 163. SPAIN SMART INHALERS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 164. SPAIN SMART INHALERS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 165. SPAIN SMART INHALERS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 166. SPAIN SMART INHALERS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
  • TABLE 167. SWEDEN SMART INHALERS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 168. SWEDEN SMART INHALERS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 169. SWEDEN SMART INHALERS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 170. SWEDEN SMART INHALERS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
  • TABLE 171. SWITZERLAND SMART INHALERS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 172. SWITZERLAND SMART INHALERS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 173. SWITZERLAND SMART INHALERS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 174. SWITZERLAND SMART INHALERS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
  • TABLE 175. TURKEY SMART INHALERS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 176. TURKEY SMART INHALERS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 177. TURKEY SMART INHALERS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 178. TURKEY SMART INHALERS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
  • TABLE 179. UNITED ARAB EMIRATES SMART INHALERS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 180. UNITED ARAB EMIRATES SMART INHALERS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 181. UNITED ARAB EMIRATES SMART INHALERS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 182. UNITED ARAB EMIRATES SMART INHALERS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
  • TABLE 183. UNITED KINGDOM SMART INHALERS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 184. UNITED KINGDOM SMART INHALERS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 185. UNITED KINGDOM SMART INHALERS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 186. UNITED KINGDOM SMART INHALERS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
  • TABLE 187. SMART INHALERS MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 188. SMART INHALERS MARKET, FPNV POSITIONING MATRIX, 2023